ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd (ENLV)

1,20
0,04
(3,45%)
Geschlossen 13 März 9:00PM
1,20
0,00
(0,00%)
Nach Börsenschluss: 10:48PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
1,20
Gebot
1,15
Fragen
1,20
Volumen
78.684
1,16 Tagesbereich 1,24
0,8101 52-Wochen-Bereich 4,59
Marktkapitalisierung
Handelsende
1,16
Handelsbeginn
1,18
Letzte Trade
1
@
1.2
Letzter Handelszeitpunkt
Finanzvolumen
US$ 92.954
VWAP
1,1814
Durchschnittliches Volumen (3 Mio.)
137.722
Ausgegebene Aktien
20.880.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,84
Gewinn pro Aktie (EPS)
-1,39
Erlöse
-
Nettogewinn
-29,07M

Über Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Ness Ziona, Center, Isr
Gegründet
-
Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENLV. The last closing price for Enlivex Therapeutics was US$1,16. Over the last year, Enlivex Therapeutics shares have traded in a share price range of US$ 0,8101 to US$ 4,59.

Enlivex Therapeutics currently has 20.880.000 shares in issue. The market capitalisation of Enlivex Therapeutics is US$24,22 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.84.

ENLV Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.1514.28571428571.051.291.022395501.16654169CS
40.1817.64705882351.021.290.93872400751.08003278CS
12001.21.290.93871377221.11786379CS
26-0.14-10.4477611941.341.760.81011988391.25999574CS
52-2.64-68.753.844.590.81011547871.51737423CS
156-4.1-77.3584905665.38.640.8101826212.39978808CS
260-4.37-78.45601436275.5729.40.81011729868.68533645CS

ENLV - Frequently Asked Questions (FAQ)

What is the current Enlivex Therapeutics share price?
The current share price of Enlivex Therapeutics is US$ 1,20
How many Enlivex Therapeutics shares are in issue?
Enlivex Therapeutics has 20.880.000 shares in issue
What is the market cap of Enlivex Therapeutics?
The market capitalisation of Enlivex Therapeutics is USD 24,22M
What is the 1 year trading range for Enlivex Therapeutics share price?
Enlivex Therapeutics has traded in the range of US$ 0,8101 to US$ 4,59 during the past year
What is the PE ratio of Enlivex Therapeutics?
The price to earnings ratio of Enlivex Therapeutics is -0,84
What is the reporting currency for Enlivex Therapeutics?
Enlivex Therapeutics reports financial results in USD
What is the latest annual profit for Enlivex Therapeutics?
The latest annual profit of Enlivex Therapeutics is USD -29,07M
What is the registered address of Enlivex Therapeutics?
The registered address for Enlivex Therapeutics is 14 EINSTEIN STREET, NESS ZIONA, CENTER, 7403618
What is the Enlivex Therapeutics website address?
The website address for Enlivex Therapeutics is www.enlivex.com
Which industry sector does Enlivex Therapeutics operate in?
Enlivex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CRVOCervoMed Inc
US$ 6,15
(160,59%)
154M
ZENAZenaTech Inc
US$ 4,5505
(61,94%)
6,88M
OPRXOptimizeRx Corporation
US$ 6,265
(51,33%)
13,1M
SSPEW Scripps Company
US$ 2,05
(43,36%)
16,99M
GRPNGroupon Inc
US$ 13,9807
(43,10%)
10,42M
HITHealth In Tech Inc
US$ 1,32
(-82,31%)
16,78M
SPHLSpringview Holdings Ltd
US$ 1,24
(-79,33%)
11,08M
APDNApplied DNA Sciences Inc
US$ 0,0619
(-57,89%)
36,75M
ZYXIZynex Inc
US$ 3,39
(-51,57%)
4,05M
HEPAHepion Pharmaceuticals Inc
US$ 0,0488
(-41,90%)
81,09M
STISolidion Technology Inc
US$ 0,174899
(38,70%)
584,7M
NVDANVIDIA Corporation
US$ 115,74
(6,42%)
323,86M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,1432
(15,59%)
222,8M
VSTEVast Renewable Ltd
US$ 0,6182
(23,66%)
193,78M
CRVOCervoMed Inc
US$ 6,15
(160,59%)
158,89M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen